In cancer, amplification of the PPP1CA gene causes aberrant activation of mitogen‐activated protein kinase (MAPK) in prostate cancer,12 and in glioblastoma, nuclear PP1A expression is associated with survival of patients with p53 expressing tumours.13 This evidence concerns the gene PPP1CA and prostate cancer.